Search - tctmd.com

Displaying 541 - 560 of 3565

Sort: Relevancy | Date

Presentation TVT 2022

Avoiding PVL by Valve design in the Younger Patients

Presenter: Michael Reardon

June 08, 2022

Presentation TVT 2022

TTVR Design Requirements: Lessons From Surgery

Presenter: Vinayak Bapat

June 08, 2022

Presentation TVT 2022

10-Year Impact of TAVR Leaflet Design (Intra- versus Supra-Annular) in Mortality and Hemodynamic Performance

Presenter: Andrea Scotti

June 08, 2022

Presentation Fellows 2022

Wire/Balloon/Catheter Technology: Fundamentals of Design and Use

Presenter: Margaret McEntegart

May 06, 2022

Presentation ARCH 2022

Top Vascular Trials of the Past Three Years

Presenter: Sahil A. Parikh

April 23, 2022

Presentation ARCH 2022

Top Trials of the Past Year: Advanced Revascularization

Presenter: David G. Rizik

April 23, 2022

Presentation ARCH 2022

Below The Knee Intervention

Presenter: Vishal Kapur

April 23, 2022

Presentation ARCH 2022

Calcium Management Strategies: From Atherectomy to IVL

Presenter: Anish J. Thomas

April 23, 2022

Presentation ARCH 2022

Paclitaxel or Limus: What is the Future in Drug Eluting Therapies?

Presenter: Craig M. Walker

April 23, 2022

Presentation ACC 2022

A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions

Presenter: Alexandra Lansky

April 04, 2022

Presentation ACC 2022

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Presenter: Milind Y Desai

April 03, 2022

Presentation CTO 2022

Why Do Interventionalists Manage Coronary Calcium So Poorly Despite Great Tools to Treat It?

Presenter: Kathleen Kearney

February 25, 2022

Presentation THT 2022

Innovation in Heart Failure Trial Designs

Presenter: Ori Ben-Yehuda

February 02, 2022

Presentation THT 2022

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

Presenter: Akshay Desai

February 02, 2022

Presentation THT 2022

Design and Rationale of the CORCINCH-HF pivotal study

Presenter: Ulrich Jorde

February 01, 2022

Presentation THT 2022

AMI vs HF-Shock: They Are NOT the Same

Presenter: Navin Kapur

February 01, 2022

Presentation THT 2022

Interstitial Space Fluid / Lymphatics

Presenter: Maxim Itkin

February 01, 2022

Presentation THT 2022

DCD - Donation After Cadiac Death

Presenter: Nader Moazami

February 01, 2022

Presentation THT 2022

Recovered EF Heart Failure -- Physiology, Clinical Implications, and Treatment

Presenter: Douglas Mann

February 01, 2022

Presentation TCT 2021

TARGET Clinical Trials Roadmap & TARGET IV NA Trial Design

Presenter: Martin Leon

November 06, 2021

Advertisement

Avoiding PVL by Valve design in the Younger Patients

TTVR Design Requirements: Lessons From Surgery

10-Year Impact of TAVR Leaflet Design (Intra- versus Supra-Annular) in Mortality and Hemodynamic Performance

Wire/Balloon/Catheter Technology: Fundamentals of Design and Use

Top Vascular Trials of the Past Three Years

Top Trials of the Past Year: Advanced Revascularization

Below The Knee Intervention

Calcium Management Strategies: From Atherectomy to IVL

Paclitaxel or Limus: What is the Future in Drug Eluting Therapies?

A Randomized Trial To Confirm The Safety And Effectiveness Of Chocolate Touch Paclitaxel Coated PTA Balloon Catheter In Above The Knee Lesions

Myosin Inhibition to Defer Surgical Myectomy or Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy

Why Do Interventionalists Manage Coronary Calcium So Poorly Despite Great Tools to Treat It?

Innovation in Heart Failure Trial Designs

Efficacy of Hemodynamic-Guided Heart Failure Management in Patients Enrolled With Elevated Natriuretic Peptide Levels but Without a Recent HF Hospitalization: An Analysis of the GUIDE-HF Trial

Design and Rationale of the CORCINCH-HF pivotal study

AMI vs HF-Shock: They Are NOT the Same

Interstitial Space Fluid / Lymphatics

DCD - Donation After Cadiac Death

Recovered EF Heart Failure -- Physiology, Clinical Implications, and Treatment

TARGET Clinical Trials Roadmap & TARGET IV NA Trial Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content